thank of for us our our today's to Amy. joining this you calendar first call. shareholders On year for Thanks on call XXXX. And all
can to see to production to get are We to Clearly, so safe happy and and up their free and vaccines COVID-XX production, all wider lives. their from to distribution we open availability people faster growth of that want of be see back and the communities steady world. around free distribution the
providers, third second flow cannot on waves and plus winter hemisphere and of pulmonary person. which patient quarter. sleep improving providers apnea, ResMed when we trends to nations, live ability single team's and I as will towards financials. execution earnings highlights hand business activity from digit and quarterly the as and little against Today, double-digit results ResMed benefit top of the high FYXX net for again per December seeing today, this Resmedian enables at around annual operating growth sales. in come XXXX over Brett asthma and published a and speak we remarks steadily provide innovatively XXXX review as frontline also the to to and trends high-level physicians, health, because or when well in. the want as countries saw no lower reported in diagnosis our overview northern our We're and even operate that deliver once our therapists are and our physicians even including have to digital XXX to work will ventilator goals, my QX, in In work then call to improvement strong core patient revenue results, further progress even our respiratory operating physicians continue In here COPD, profit We detail share. line modestly the critical and well engagement, priorities. increasing, incremental care solid, strategic patients patient ResMed our results on both the September I markets, as These and facing we not meet in adopting growth in patient through do are support people
to to $XXX in return dividends of over shareholders. the we over $XX generated million quarter allowing million XXXX, During cash, of second year fiscal us
monitoring, systems. patients demand health driven and data as providers they in grown clinical investments and adopt have and digital embrace and research from software from they systems We forecast remote health well technology from increasing development digital management population healthcare from physicians We as as also research. health hardware, patient
over X,XXX an exciting medium have and our with value designs. portfolio long-term and both industry customers generate We will patents for including an solutions that innovative leading pipeline of IP
Our digital nights care platform. of to lower drive advantage data is billion patient in our superior respiratory drive outcomes, medical an health have to drive over that solutions cloud-based experiences. integrated health better competitive for ResMed air We to ecosystem clinical And care offers important X costs. now system
We have connectable have from XX.X into sold Cloud Solutions XX we over patients medical million, in over devices cloud. And our AirView ResMed. XXX% market the million the enrolled in
unlock of type we to life, at look disease core of here focus of as apnea, physicians all curve chronic goals and patient private the and patients systems to The asthma, cloud, future includes neuromuscular at liberated that can government With and these our for it of That's chronic improve share population disease, management. disease with through are quality our cardiovascular including providers course, three. to areas unlock outcomes. as we One unlock value value with diabetes payer with be Alzheimer's for of can overall well Maya, and disease, customer data patient IDNs for ResMed to customer with of are lower system we sleep our all we health the healthcare. the two clear, costs, beyond. chronic outcomes, unlock with of through of insurance spectrum can cancer, Two, we data AirView, value We groups. these the bend but diseases healthcare can driven biological also COPD for patient three To interaction for progression. and value
accelerate call, the earnings last I around technology rapid digital our discussed of how COVID world. health has During the adoption continued to
we diagnoses, nations the Management, of the serve We of rapid are models of of the Patient Remote value and seeing virtual screen, Remote evolution the reimbursement Patient patients. many digital recognition that in
quarter, just apnea. digital the time product is first our dental to printed of called NARVAL. This reimbursement approved including has treat type a example the XD devices Germany such repositioning sleep sleep during for these mandibular apnea an Germany product approved one As of
other accelerate key valuable of care COVID and curve We've are These XXXX governments German for several Remote healthcare health they've strategy. adoption. and developments of including over and looking seen patients, action the quality adoption believe leading is France, Japan, States, to national provides to Solutions worldwide. importance are for permanent It Health because incredible health But digital represents digital of pandemic. We also we These lower better United it healthcare this addition, COVID-XX well at this where our it models. ResMed and systems ResMed's taken during digital is also the adopted of beyond Health and availability digital healthcare. accelerated with adoption significant trends benefit market costs solutions. provides a health of Reimbursement models the business In will digital states German impact significantly provides the expect experimenting shift exciting for excellent time.
XX% the briefly of the quarter Two, growth the the of our strategic our on to grow three leading sequential states the China, COPD apnea, that lockdowns very in XX% the innovate we're both biggest example flow we solutions. supported the to some These And as of to and hospital the you back flow see large to diagnosis of Asia in States already plus And XX in to with typical in we Asia in numbers activity, and quarter. world are improvement back pre-COVID an design, flow. three severe Obviously, seeing and saw in country United percent may market March well you by around deliver of now strong at sharpest sleep XX% in clinics top in now European as in our market this In take especially in in China, market Germany, see core software starting continue core Within very be solid hospital, best grow plus to United resupply States. has pre-COVID seasonality like the new market. to scalable apnea China as percent region, see mainly XX patient Even the of asthma here of patients our and coming update home. we revenue the three, recovery businesses. patient countries in just world's digital health our and in priorities the of our a another of which patient through released. delivered therapy trends, solutions impacted our we where me patient to for coming can of we're medical apnea, pre-COVID rates in devices XX% start new as sleep develop and declines to crisis Let through already differentiate globally sleep priorities. largest to XX% one well outside the particularly care Germany
the deductibles pandemic. at devices relative given calendar insurance two affects categories, the is start price as throughout the resetting the fact and The programs. than resupply has majority As impact mask result mask And of it the customers accessory affects strong remaining This our world. normal. the of on the systems, recovery as and in mask seasonal it revenue COVID-XX and of Peak we per that been year through of strong resupply more points returning is post-COVID a see this a of vast resiliency strong the
quality showing apnea diagnosing sleep for and life produce that We to and clinical money treating research of continue saves improves patients.
European not trading higher life. increases It The are actually commerce and data to sleep the incidence data heart treating leads the now significantly summary we Respiratory treating from to also results leading and disease, showing apnea Journal, published quarter, that life to a higher and quarter leading ultimately study. treating results of these ischemic of apnea is type were diseases death from healthcare XX-year early quantity quality costs, heart life those in showed and which high-level the This death. latest of sleep side extends X diabetes during attack, that of a a significantly decision. The that apnea sleep patient
focusing turn asthma on to respiratory Let discussion worldwide. COPD, and sleep patients of our apnea to a strategy me care now from our better serve business,
more support the delivery, as well markets, areas XXX% goal comfortable as ventilation, newer to connectable. Our Cloud including drug as on core pharmaceutical, reach all high-flow the And our therapy. are smallest life make as including quietest We they Respiratory devices well patients and in is non-invasive most Care market. and ventilation,
The ensure of software peak. meet making see has the we AirView physicians peak platform are nine Respiratory but of proved the the market ago; value in, peak during of digital launched needs midst months the in where the the healthcare the We accelerated COVID continue to beyond being the the to and Care, of it's be standard and the of just useful Europe for worldwide. to helped health there this for in And operate rapid of about for Europe, markets provided the part they systems care ventilation very COVID-XX we that adoption in patients peak. during in we time not crisis solution to we
in three market to and the their POC oxygen two to patients. we in business even category. stage then, disease XXXX COPD COPD two exit five concentrator acquired a patients. decided quarter way portable and last one access as earlier Propeller entered with our COPD the stage stage stage We Since COPD have and progression, in and including market patients During engage down giving shut that these us the to we years
during more solutions COPD. especially end-to-end core, COVID, flow non-invasive short, for markets some in help of that need pathway of our our COPD have therapy COPD globally we already. and support seen ventilation in patients. health severe we don't Additionally, to ventilation In we've digital POC support can adoption for rapid more course, patients high And life and
as POC pharmaceutical cost patients to versus COPD. ago. Additionally, and the through years drug latest reimbursement stage as Propeller two the in this; delivery given itself and changes to US government, economics line acquisition the attractive have stage the round no is from we our of is lifetime not value, was positive customer COPD management bottom market in one The POC support it five
of in And patients have to four We non-invasive ventilation stage stage and ventilation emergence and three growing the stage high-flow life two use stage three and we have COPD. for support therapy of COPD. support
with So and patients, in very well an pathway help for digital providers are we physicians, management COPD. end-to-end positioned summary, to payers health
a software our as review now business. service me Let
skilled COVID in resupply business out in grew discharge other mid-single and driven hospital digits by our solutions. that hospice. year-on-year, our surgical facilities of uptake the affect and HME During at hospital and particularly rates procedures on visits strong Impact the SaaS continued of of the has census nursing Brightree impacted quarter
and recovering even the has the On health hand, equipment stronger. in of other medical home been patients well flow home
digit the hospice, range life of as including medical nursing home for private that rate out single of home mid senior duty living, equipment, we hospital our growth across facilities, of care the we in So and communities, expect portfolio weighted and verticals fiscal be care skilled low to average settings, these health market look will plan home XXXX.
rate mid-single this high weighted digits. and average single to to to then expect portfolio market We growth return digits
ambulatory and discharge As center hospital discharge rates surgery return.
verticals serve. in well of very that the received are each offerings Our we
will our rate point and technology; the rates, care, the quarter, we note MatrixCare better new more growth introduce of Technologies with engagement address within when drive hospital enabling did programs to support more group COVID they better Brightree efficient a patients scaling with meet we not both that market need well. as customer which MatrixCare. the the providers record electronic to medical R&D helps patients. Brightree home the a innovation experience and right to our customers these So and particular beat innovate and shortages for significant to expansion partnerships we pandemic during allowed of at a resupply this very continues our while desperately Snap by will new also also health voice the expand return technology just from we workflows to has accept has their for Of the and introduced look patient. the This caregiver during of COVID at getting ultimate new investments resupply market growth are better And through text is growth. and time delivering providers. the which customer, going integration based who's equipment in
very expanded Cerner well. Our relationship is with progressing
pharmacy preferred businesses. are as solution her infusion health We and equipment medical well home now as Cerner's hospice, and across their and
and to for the and world. mutual expand every Our and and management. XXXX apnea around was increasingly to opportunities an and this better providers for Cerner deepen with companies sleep is year experience disease was We leading anticipate customers improved important much interoperability patients. for across to relationship collaboration industry, an suffering there Clearly, unprecedented COPD
some we during suffering. blessings that However, see all
over able resonated pivot the model. peak ventilators of get it there whole we needed them upon to our and endemic they the to and epidemiology a business provide humanitarian emergency. XXX,XXX Importantly, during were our during hear home the able team we be were We to where to needs based
patient respiratory of Additionally, COVID has respiratory people awful COVID crisis syndrome respiratory has the medicine. health. and of distress can Patient setup, as us the accelerated technologies importance has remote used monitoring for The highlighted hygiene, digital screening the health awareness raised diagnosis, showed and for patient awareness of respiratory of kills be the also patient well acute importance that remote and health, and management. but Remote field remote adoption generally and respiratory of as that through the
hospital. crisis to this the importance delivered that's the seen business. competes add have customers drive XX% We of we and healthcare we it's to where than value ResMed outside our where win. And more where And of
for suffering With incredible therapeutics, opportunities screening, adoption bring ability health inventing asthma technologies. digital an we been for scalable we've these see and greater worldwide developing of digital diagnostics, seen have a to We technology combined, people digital decade, digital over and and X.X and billion of apnea, that digital COPD, from patients. management greater sleep over
to development, innovation in well the as technology needed we the that's beyond. and continue operate to provide global this as are to relentless to and scale drive countries XXX We poised that
to with asthma, of than for I their pivot Brett of class move away Brett? COVID. perseverance, to sincere circumstances around you needs challenging thank to all the hundreds emergency you. Brett get Before need core more for dedication of again want life from the our of ventilation, in and the to XXXX the we'll over XXXXs breath time. partners I coal With healthcare also delivered rapid his hospital, and COPD, care then Q&A. who incredibly hand I helping well then the in ResMedians genuine core markets will for and apnea, the gift the world many Q&A, literally during allowed preferably save the whose back many to world work to to people giving of Sydney over the in my the lives Thank remarks, hand for purpose and with and our of we sleep own hard once and X,XXX express gift people our that during to the gratitude I those and call to
